EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clusterin Promotes the Migration and Invasion of Highly Aggressive Breast Cancer Cells Through Molecular Mechanisms That Affect the Cell Cytoskeleton and Extracellular Matrix Dynamics

Alessia Ciringione iD, Marina Marozzi, Silvana Belletti iD, Margot Lo Pinto iD, Simone Dario Scilabra iD, Patrizia Cancemi iD, Federica Rizzi iD

International Journal of Molecular Sciences · 10.02.2026 · 27 (4) · 1721

DOI: 10.3390/ijms27041721 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.02.2026. Verfasst von Alessia Ciringione und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry, Molecular Biology and Oncometabolism, Department of Medicine and Surgery, University of Parma, Via Volturno 39, 43125 Par…. Hauptthemen laut MEDLINE: Clusterin, Cell Movement, Breast Neoplasms, Extracellular Matrix. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: (MUR) Italian Ministry of Research, MUR PRIN 2017.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic breast cancer (BC) remains a major clinical challenge, and identifying molecular mechanisms driving tumor cell migration and invasion is critical to develop effective therapeutic strategies. Clusterin (CLU), a secreted chaperone-like protein, is upregulated in BC and metastatic tissue; however, its functional contribution to tumor aggressiveness remains unclear. Here, we silenced CLU by siRNA in two BC cell lines with distinct aggressiveness and examined its impact on migration, invasion, and associated signaling pathways. Following CLU silencing, cell migration and invasion were assessed using transwell assays. Cytoskeletal organization was evaluated by F-actin staining, while downstream signaling pathways were analyzed by RT-PCR, Western blotting, and Rho GTPase pull-down. A comparative proteomic analysis was performed in CLU-expressing and CLU-silenced MDA-MB-231 cells. CLU knockdown significantly reduced migration and invasion in MDA-MB-231, concomitantly with loss of F-actin-rich membrane protrusions, reduced expression of MMP9, COL1A1, and COL4A1, and decreased activation of Akt, NF-κB, and RhoA. Proteomic profiling revealed extensive remodeling of pathways involved in cell adhesion, cytoskeletal dynamics, and extracellular matrix interactions. Differently, no or very mild effects were observed in CLU-silenced MCF-7 cells. These findings identify CLU as an upstream regulator of a pro-metastatic adhesion–cytoskeleton signaling in BC, selectively operative in EMT-engaged, basal-like cells, highlighting the importance of patient stratification for CLU-targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClusterinCell MovementBreast NeoplasmsExtracellular MatrixCytoskeletonHumansFemaleNeoplasm InvasivenessMDA-MB-231 CellsSignal TransductionCell Line, TumorGene Expression Regulation, NeoplasticProteomics

Stichwörter der Autor:innen

CLUcell cytoskeletoncell invasioncell migrationclusterinextracellular matrixmetastatic breast cancer

Substanzen

ClusterinCLU protein, human

Autor:innen und Institutionen

  • Laboratory of Biochemistry, Molecular Biology and Oncometabolism, Department of Medicine and Surgery, University of Parma, Via Volturno 39, 43125 Parma, Italy.
  • Histology and Embryology Laboratory, Department of Medicine and Surgery, University of Parma, Via Volturno 39, 43126 Parma, Italy.
  • Proteomics Group of Ri.MED Foundation, Research Department, IRCCS ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Via E. Tricomi 5, 90127 Palermo, Italy.
  • Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale Delle Scienze, Ed. 16, 90128 Palermo, Italy.
  • National Institute of Biostructure and Biosystems (INBB), 00136 Rome, Italy.
  • COMT-Center for Molecular and Translational Oncology, 43124 Parma, Italy.

ORCID-Profile: Alessia Ciringione, Silvana Belletti, Margot Lo Pinto, Simone Dario Scilabra, Patrizia Cancemi, Federica Rizzi

Förderung

  • (MUR) Italian Ministry of Research
  • MUR PRIN 2017

Zitieren

APA

Ciringione, A., Marozzi, M., Belletti, S., Lo Pinto, M., Scilabra, S. D., Cancemi, P., & Rizzi, F. (2026). Clusterin Promotes the Migration and Invasion of Highly Aggressive Breast Cancer Cells Through Molecular Mechanisms That Affect the Cell Cytoskeleton and Extracellular Matrix Dynamics. International Journal of Molecular Sciences, 27(4), 1721. https://doi.org/10.3390/ijms27041721

Vancouver

Ciringione A, Marozzi M, Belletti S, Lo Pinto M, Scilabra SD, Cancemi P, et al. Clusterin Promotes the Migration and Invasion of Highly Aggressive Breast Cancer Cells Through Molecular Mechanisms That Affect the Cell Cytoskeleton and Extracellular Matrix Dynamics. International Journal of Molecular Sciences. 2026;27(4):1721. doi:10.3390/ijms27041721

BibTeX
@article{Ciringione2026,
  author = {Ciringione, Alessia and Marozzi, Marina and Belletti, Silvana and Lo Pinto, Margot and Scilabra, Simone Dario and Cancemi, Patrizia and Rizzi, Federica},
  title = {Clusterin Promotes the Migration and Invasion of Highly Aggressive Breast Cancer Cells Through Molecular Mechanisms That Affect the Cell Cytoskeleton and Extracellular Matrix Dynamics},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {4},
  pages = {1721},
  doi = {10.3390/ijms27041721}
}
Kostenlos starten →